Dysmenorrhea
Introduction
Dysmenorrhea, defined as painful menstruation, is one of the most common gynecologic complaints encountered in Canadian primary care and emergency settings. For MCCQE1 preparation, it is crucial to distinguish between primary and secondary dysmenorrhea, as the investigation and management pathways differ significantly.
Understanding dysmenorrhea aligns with the CanMEDS Medical Expert role, requiring the integration of pathophysiology, clinical skills, and professional values (especially when dealing with adolescent populations).
Definition: Dysmenorrhea is defined as cramping pain in the lower abdomen occurring just before or during menstruation. It is classified into two types:
- Primary: Pain without pelvic pathology.
- Secondary: Pain associated with underlying pelvic pathology.
Epidemiology in Canada
- Prevalence: Affects approximately 60-90% of adolescent girls and women of reproductive age in Canada.
- Impact: It is a leading cause of school and work absenteeism, highlighting the Health Advocate role in ensuring adequate symptom management to improve quality of life.
Classification and Pathophysiology
For the MCCQE1, you must be able to categorize the patient’s presentation rapidly.
Primary Dysmenorrhea
Onset: Usually begins 6–12 months after menarche (once ovulatory cycles are established).
Pathophysiology:
- Mediated by excessive production of endometrial prostaglandins (specifically PGF2) during the secretory phase.
- Increased uterine contractility leads to ischemia and pain.
- Risk Factors: Early menarche (<12 years), nulliparity, heavy menstrual flow, smoking, family history.
Key Abbreviations
PGF2a: Prostaglandin F2-alpha
NSAIDs: Non-Steroidal Anti-Inflammatory Drugs
OCPs: Oral Contraceptive Pills
PID: Pelvic Inflammatory Disease
SOGC: Society of Obstetricians and Gynaecologists of CanadaClinical Assessment
A structured approach to history and physical exam is vital for the Clinical Decision Making (CDM) component of the MCCQE1.
History Taking
Step 1: Characterize the Pain
Use the SOCRATES method.
- Timing: Primary dysmenorrhea starts 1–2 days before or with the onset of bleeding and lasts 12–72 hours. Pain persisting throughout the cycle suggests secondary causes (e.g., endometriosis).
- Nature: Cramping, spasmodic, lower abdominal. May radiate to the lower back or anterior thighs.
Step 2: Associated Symptoms
- Systemic symptoms due to prostaglandin spillover: Nausea, vomiting, diarrhea, fatigue, headache.
- Red Flags: Dyspareunia, dyschezia, heavy menstrual bleeding (menorrhagia), intermenstrual bleeding.
Step 3: Menstrual and Sexual History
- Age of menarche.
- Cycle regularity and duration.
- Sexual history (screen for STIs/PID risk).
- Contraceptive use (IUDs can cause pain; OCPs generally relieve it).
Physical Examination
Canadian Practice Point
In an adolescent who is not sexually active and presents with a classic history of primary dysmenorrhea, a pelvic examination is not required before initiating empiric therapy. This respects the patient’s autonomy and comfort.
- Abdominal Exam: Check for masses or tenderness.
- Pelvic Exam (if indicated):
- Speculum: Inspect for cervical discharge (PID), polyps, or anomalies.
- Bimanual: Assess for uterine size (fibroids, adenomyosis), adnexal masses, or cervical motion tenderness (PID).
- Rectovaginal: May be necessary to assess for deep infiltrating endometriosis (nodularity on uterosacral ligaments).
Differential Diagnosis
The following table summarizes key features helping to distinguish causes of secondary dysmenorrhea, a frequent topic in MCCQE1 case scenarios.
| Condition | Clinical Features | Diagnostic Clues |
|---|---|---|
| Endometriosis | Cyclical pelvic pain, dyspareunia, dyschezia, infertility. | Fixed retroverted uterus, tender uterosacral ligaments. |
| Adenomyosis | Dysmenorrhea + Heavy Menstrual Bleeding (HMB) in multiparous women >40. | Boggy, tender, uniformly enlarged uterus. |
| Fibroids | HMB, pelvic pressure/bulk symptoms. | Irregularly enlarged, firm, non-tender uterus. |
| PID | New onset pain, vaginal discharge, fever, recent new sexual partner. | Cervical motion tenderness, adnexal tenderness. |
| Ovarian Cysts | Unilateral pain, may be acute (torsion/rupture). | Adnexal mass on exam. |
Investigations
Investigations are guided by the history and physical. Do not order “routine” labs for classic primary dysmenorrhea.
- Primary Dysmenorrhea: Clinical diagnosis. No investigations needed initially.
- Secondary Dysmenorrhea (or failure of empiric therapy):
- Pregnancy Test (Beta-hCG): Rule out ectopic pregnancy or complications of pregnancy.
- Swabs: NAAT for Chlamydia and Gonorrhea (if sexually active/risk factors).
- Imaging: Transvaginal Ultrasound (TVUS) is the first-line imaging modality in Canada.
- Laparoscopy: The gold standard for diagnosing endometriosis if medical management fails.
Canadian Management Guidelines (SOGC)
Management strategies should follow the Society of Obstetricians and Gynaecologists of Canada (SOGC) guidelines (Guideline No. 345).
1. Non-Pharmacologic Management
- Heat: Continuous low-level topical heat is as effective as ibuprofen.
- Exercise: Regular exercise may reduce symptoms.
- Dietary: Some evidence for Vitamin B1, B6, E, and Magnesium.
- Behavioral: Smoking cessation (smoking increases dysmenorrhea risk).
2. Pharmacologic Management
MCCQE1 High-Yield Concept
Therapy is often initiated empirically. A lack of response to NSAIDs and OCPs increases the likelihood of a secondary cause, specifically endometriosis.
First Line: NSAIDs
- Mechanism: Inhibit Cyclooxygenase (COX) enzymes, reducing prostaglandin production.
- Regimen: Start at the onset of menses (or 1-2 days prior) and continue for 2-3 days.
- Options: Ibuprofen, Naproxen, Mefenamic Acid.
- Efficacy: Effective in 70-90% of primary dysmenorrhea cases.
Second Line: Hormonal Contraceptives
- Mechanism: Suppress ovulation and limit endometrial proliferation (reducing prostaglandin source).
- Options: Combined Oral Contraceptives (COCs), Progestin-only pills, Depot medroxyprogesterone acetate, Levonorgestrel-releasing IUD (Mirena/Kyleena).
- Note: COCs may be used continuously to induce amenorrhea.
3. Surgical Management
- Reserved for secondary causes (e.g., myomectomy for fibroids, excision for endometriosis).
- Laparoscopic Uterosacral Nerve Ablation (LUNA): generally not recommended due to lack of long-term efficacy.
Management Checklist
- Assess patient goals (contraception needed?)
- Rule out pregnancy
- Trial of NSAIDs for 3 cycles
- If NSAIDs fail/contraindicated, trial of Hormonal Contraceptives for 3 cycles
- If both fail, consider combination therapy or investigate for secondary causes (Ultrasound/Referral)
Key Points to Remember for MCCQE1
- Diagnosis: Primary dysmenorrhea is a diagnosis of exclusion; however, extensive workup is not needed for typical adolescent presentations.
- Adolescent Health: Always interview adolescents alone for part of the visit to ensure confidentiality regarding sexual history (CanMEDS Professional).
- Treatment Failure: If a patient does not respond to adequate trials of NSAIDs and hormonal suppression, suspect Endometriosis.
- Imaging: Ultrasound is the modality of choice for pelvic pathology; CT is rarely indicated for gynecologic causes of dysmenorrhea.
- Mnemonic for Secondary Causes: “4 P’s”
- Pregnancy (Ectopic/Abortion)
- PID (Infection)
- Pathology (Endometriosis, Adenomyosis, Fibroids)
- Plumbing (Congenital anomalies)
Sample Question
A 16-year-old female presents to her family physician complaining of painful menstruation. She achieved menarche at age 13, and her cycles are regular, occurring every 28 days and lasting 5 days. For the past year, she has experienced cramping lower abdominal pain starting on the first day of bleeding and resolving by day 3. She reports nausea and fatigue during these episodes. She has missed school twice in the last 4 months due to the pain. She is not sexually active and has no significant past medical history. Her physical examination, including abdominal palpation, is unremarkable.
Which one of the following is the most appropriate initial management for this patient?
Detailed Explanation: This patient presents with a classic history of primary dysmenorrhea: onset shortly after menarche, cyclical pain associated with menses, systemic prostaglandin symptoms (nausea/fatigue), and a normal abdominal exam.
- Option D is correct: NSAIDs (like Naproxen or Ibuprofen) are the first-line pharmacologic treatment for primary dysmenorrhea. They work by inhibiting prostaglandin synthesis, which is the underlying pathophysiology. They should be started at the onset of menses or 1-2 days prior.
- Option A is incorrect: In a typical presentation of primary dysmenorrhea in an adolescent who is not sexually active, pelvic imaging is not indicated initially. It is reserved for patients with atypical features or those who fail empiric therapy.
- Option B is incorrect: Narcotics are not first-line therapy for dysmenorrhea and carry a risk of dependence.
- Option C is incorrect: While COCs are an effective treatment (often considered second-line or first-line if contraception is desired), NSAIDs are generally the initial choice if the patient does not require contraception, given the patient’s age and profile. However, COCs would be a reasonable alternative if NSAIDs fail or if the patient requested birth control.
- Option E is incorrect: Laparoscopy is invasive and reserved for cases refractory to medical management or when there is a high suspicion of endometriosis that cannot be managed medically.
References
- Burnett, M., & Lemyre, M. (2017). No. 345-Primary Dysmenorrhea Consensus Guideline. Journal of Obstetrics and Gynaecology of Canada, 39(7), 585-595. SOGC Clinical Practice Guideline
- Medical Council of Canada. (n.d.). MCCQE Part I Clinical Decision-Making and Multiple-Choice Question Objectives.
- Toronto Notes 2024. Gynecology Chapter.
- UpToDate. (2024). Dysmenorrhea in adult women: Clinical features and diagnosis.
- UpToDate. (2024). Dysmenorrhea in adult women: Treatment.